Cybin Inc (NYSE American:CYBN)
| 0.533 Delayed Data As of Sep 29 |  +0.0446 / +9.13%Today’s Change | 0.21 Today|||52-Week Range 0.72 | +79.40% Year-to-Date |
Latest CYBN News | Press Releases
No recent news for Cybin Inc.
Today’s Trading
| Previous close | 0.49 |
| Today’s open | 0.49 |
| Day’s range | 0.48 - 0.54 |
| Volume | 4,009,170 |
| Average volume (3 months) | 3,675,364 |
| Market cap | $129.1M |
Data as of 3:59pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +39.95% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.10 |
Competitors
Data as of 11:00am ET, 09/27/2023
Financials
| Next reporting date | November 29, 2023 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$35.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Toronto, Ontario |
Forecasts
